The Potential of Proton Therapy for Locally Advanced Breast Cancer: Clinical and Technical Considerations

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2023 Mar 28

PMID 36975432

Authors

N Lalani

S Alqarni

R B Jimenez

Affiliations

Soon will be listed here.

Abstract

Proton therapy is a promising therapeutic modality with unique physical properties that allow for abrupt dose fall-off distal to the target of interest, thereby sparing nearby organs at risk. A number of studies have identified the utility of proton radiation in mitigating treatment related sequelae for patients with locally advanced breast cancers. Thus, in the following review, we highlight clinical and technical considerations for proton radiotherapy delivery in patients with locally advanced breast cancer.

Citing Articles

Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017.

Gellings J, Cortina C, Kijak J, Bradley J, Aldakkak M, Bergom C Surg Oncol Insight. 2024; 1(4).

PMID: 39555478 PMC: 11566854. DOI: 10.1016/j.soi.2024.100093.

Exploring Helium Ions' Potential for Post-Mastectomy Left-Sided Breast Cancer Radiotherapy.

Bonaccorsi S, Tessonnier T, Hoeltgen L, Meixner E, Harrabi S, Horner-Rieber J Cancers (Basel). 2024; 16(2).

PMID: 38254899 PMC: 10814201. DOI: 10.3390/cancers16020410.

The Coming of Age of Breast Radiotherapy.

Corn B, Galper S, Ben-David M Curr Oncol. 2023; 30(5):5179-5181.

PMID: 37232850 PMC: 10217691. DOI: 10.3390/curroncol30050392.

References

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Brunt A, Haviland J, Wheatley D, Sydenham M, Alhasso A, Bloomfield D . Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020; 395(10237):1613-1626. PMC: 7262592. DOI: 10.1016/S0140-6736(20)30932-6. View

Paganetti H, Blakely E, Carabe-Fernandez A, Carlson D, Das I, Dong L . Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019; 46(3):e53-e78. PMC: 9559855. DOI: 10.1002/mp.13390. View

Barton M, Jacob S, Shafiq J, Wong K, Thompson S, Hanna T . Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014; 112(1):140-4. DOI: 10.1016/j.radonc.2014.03.024. View

van den Bogaard V, Ta B, van der Schaaf A, Bouma A, Middag A, Bantema-Joppe E . Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. J Clin Oncol. 2017; 35(11):1171-1178. PMC: 5455600. DOI: 10.1200/JCO.2016.69.8480. View

Darby S, Ewertz M, McGale P, Bennet A, Blom-Goldman U, Bronnum D . Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368(11):987-98. DOI: 10.1056/NEJMoa1209825. View

Paganetti H, Depauw N, Johnson A, Forman R, Lau J, Jimenez R . The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques. Radiother Oncol. 2020; 149:212-218. PMC: 11293368. DOI: 10.1016/j.radonc.2020.05.035. View

Fattahi S, Mullikin T, Aziz K, Afzal A, Smith N, Francis L . Proton therapy for the treatment of inflammatory breast cancer. Radiother Oncol. 2022; 171:77-83. DOI: 10.1016/j.radonc.2022.04.008. View

Panchal H, Pilewskie M, Sheckter C, Albornoz C, Razdan S, Disa J . National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer. J Surg Oncol. 2018; 119(1):79-87. PMC: 6327316. DOI: 10.1002/jso.25315. View

10.

Slater J, Archambeau J, Miller D, Notarus M, Preston W, Slater J . The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. Int J Radiat Oncol Biol Phys. 1992; 22(2):383-9. DOI: 10.1016/0360-3016(92)90058-p. View

11.

Stick L, Yu J, Maraldo M, Aznar M, Pedersen A, Bentzen S . Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2017; 97(4):754-761. PMC: 5625081. DOI: 10.1016/j.ijrobp.2016.12.008. View

12.

MacDonald S, Jimenez R, Paetzold P, Adams J, Beatty J, DeLaney T . Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery. Radiat Oncol. 2013; 8:71. PMC: 3627609. DOI: 10.1186/1748-717X-8-71. View

13.

Garda A, Hunzeker A, Michel A, Fattahi S, Shiraishi S, Remmes N . Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric Comparison. Adv Radiat Oncol. 2022; 7(3):100901. PMC: 9133394. DOI: 10.1016/j.adro.2022.100901. View

14.

Taylor A, Powell M . Intensity-modulated radiotherapy--what is it?. Cancer Imaging. 2008; 4(2):68-73. PMC: 1434586. DOI: 10.1102/1470-7330.2004.0003. View

15.

Mutter R, Choi J, Jimenez R, Kirova Y, Fagundes M, Haffty B . Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee. Int J Radiat Oncol Biol Phys. 2021; 111(2):337-359. PMC: 8416711. DOI: 10.1016/j.ijrobp.2021.05.110. View

16.

Liu C, Zheng D, Bradley J, Vega R, Zhang Y, Indelicato D . Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans. Acta Oncol. 2020; 60(2):252-259. DOI: 10.1080/0284186X.2020.1834141. View

17.

Jimenez R, Hickey S, Depauw N, Yeap B, Batin E, Gadd M . Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation. J Clin Oncol. 2019; 37(30):2778-2785. PMC: 7351324. DOI: 10.1200/JCO.18.02366. View

18.

Brown A, Suit H . The centenary of the discovery of the Bragg peak. Radiother Oncol. 2004; 73(3):265-8. DOI: 10.1016/j.radonc.2004.09.008. View

19.

Grantzau T, Thomsen M, Vaeth M, Overgaard J . Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014; 111(3):366-73. DOI: 10.1016/j.radonc.2014.05.004. View

20.

Gokula K, Earnest A, Wong L . Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas. Radiat Oncol. 2013; 8:268. PMC: 3842634. DOI: 10.1186/1748-717X-8-268. View